China Digest: Lynk Pharma, Bestzyme Bioengineering bag funds
Biopharmaceutical firm Lynk Pharmaceuticals has bagged 200 million yuan ($28.2 million) in its Series C1 round, according to a release.
Source: dealstreetasia.com
Page 8 - Genscript Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Genscript Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Genscript Biotech Today - Breaking & Trending Today
GenScript Debuts GenTitan Gene Fragments Service to Expedite Gene Synthesis at Lower Cost
Traditional DNA synthesis has long been plagued by slow, low-quality results, creating a bottleneck for researchers and impeding progress in both academic and industrial fields; in response,... | May 23, 2023
Source: marketscreener.com
GenScript to Debut Expanded Synthetic Biology Product Line at SynBioBeta 2023
/PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, is a sponsor of this year's SynBioBeta...
Source: prnewswire.com
GenScript Expands Peptide and Oligonucleotide Production Facility in China
/PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its primary manufacturing...
Source: prnewswire.com
Genscript Biotech Co. (OTCMKTS:GNNSF) Sees Significant Growth in Short Interest
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Rating) saw a large increase in short interest in April. As of April 30th, there was short interest totalling 5,524,500 shares, an increase of 31.8% from the April 15th total of 4,192,500 shares. Based on an average daily volume of 2,900 shares, the days-to-cover ratio is currently 1,905.0 days. […]
Source: wkrb13.com